Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PJP vs. FTXH: which is better?

Bottom line

PJP vs FTXH: the short answer

PJP (Invesco Pharmaceuticals ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 44% by weight.

PJP is cheaper at 0.58% vs 0.6% — a difference of $2.00 a year per $10,000 invested.

Over five years, PJP returned +9.0% a year vs +6.5% for FTXH.

Updated Nov 19, 2026

PJP vs FTXH side by side

PJPFTXH
TypeETFETF
Fund familyInvescoFirst Trust
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.58%0.6%
Annual cost per $10k$58$60
10-yr cost on $10k (prospectus)$726—
Max front loadNoneNone
12b-1 fee—0%
1-yr return+27.9%+24.0%
5-yr return (annualized)+9.0%+6.5%
10-yr return (annualized)+5.1%—
Best quarter+18.1%+18.3%
Worst quarter−14.8%−17.4%
Net assets (fund)$472.1M$36.2M
Number of holdings3351
Portfolio turnover36%35%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPJPFTXHDifference
2025+27.9%+24.0%+3.9%
2024+9.7%+3.0%+6.8%
2023−2.2%−1.4%−0.8%
2022−2.0%+2.5%−4.5%
2021+14.5%+6.1%+8.4%
2020+11.2%+10.9%+0.3%
2019+4.7%+22.4%−17.7%
2018−1.7%−8.4%+6.7%
2017+15.3%+18.8%−3.5%

Source: Fund prospectus bar charts

Holdings overlap

11 of PJP's top 25 holdings also appear in FTXH's top 25.

Shared top holdings
HoldingPJPFTXH
AbbVie Inc.5.48%7.39%
Amgen Inc.5.33%3.18%
Johnson & Johnson5.18%6.96%
Merck & Co., Inc.5.06%7.07%
Eli Lilly and Co.5.02%7.77%
Gilead Sciences, Inc.4.53%2.89%
Pfizer Inc.4.50%2.97%
Regeneron Pharmaceuticals, Inc.3.14%2.72%
Bristol-Myers Squibb Co.2.94%6.29%
Viatris Inc.2.83%3.62%
Biogen Inc.2.75%3.84%

Source: SEC Form N-PORT

PJP top 10

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Merck & Co., Inc. — 5.06%
  7. Eli Lilly and Co. — 5.02%
  8. Corcept Therapeutics Inc. — 4.96%
  9. Gilead Sciences, Inc. — 4.53%
  10. Pfizer Inc. — 4.50%

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

FAQ

What is the difference between PJP and FTXH?
PJP (Invesco Pharmaceuticals ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 44% by weight. PJP is cheaper at 0.58% vs 0.6% — a difference of $2.00 a year per $10,000 invested.
Which is cheaper, PJP or FTXH?
PJP has the lower expense ratio (0.58%).
Should I own both PJP and FTXH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.